Abstract:Anticancer activities of platinum (II) complexes are modulated by the chelated phosphine ligands, with more azadiphosphines resulting in more cytotoxicity. This work reports the preparations and anticancer activities of a set of platinum (II) complexes. Two types of bidentate ligands, azadiphosphine (PNP) and diphosphine (PP), were applied to afford different kinds of platinum centers, the homoleptic complexes, [Pt (PNP)2]2+ (1 and 2) and [Pt (PP)2]2+ (4), and the hybrid complex, [Pt (PNP)(PP)]2+ (3). All these complexes are characterized by various analytical techniques, and their structures were validated using single‐crystal X‐ray diffraction analysis. Notably, the stability of the complexes 1–4 is differentiated both in phosphate‐buffered saline (PBS) and in the culture media (RPMI‐1640), relative to the type of coordinated diphosphine ligands, specifically, the more PNP ligands, the less stability. The bite angles of P‐Pt‐P bonds in 1–4 would be reliant on their stability, so that complexes 1 and 2 with small bite angles tend to be labile. A mechanistic understanding on the decomposition of 2 is proposed with the aid of mass analysis. As a result, their anticancer activities should be also associated with their stability so that the chelated ligands, with more PNP ligands, lead to more cytotoxicity. Mechanistically, the poisonous platinum (II) derivatives of complex 2 should interact with the nucleus DNA, whereas the intact complex 4 is not traceable, confirming from a γ‐H2AX‐related immunofluorescence staining kit. Additionally, complex 2 exhibits severe toxicity toward several cancer cells as well as a normal cell. Furthermore, complex 2 has inhibited the formation and viability of three‐dimensional T24 mammospheres, reminding it of a promising candidate for anticancer treatments. Overall, the present work provides a way for the systematic investigation to elucidate how a bidentate diphosphine ligand modulates the stability and the anticancer activities of the corresponding square‐planner platinum (II) complex.

Bifunctional Platinum(II) Complexes with Bisphosphonates Substituted Diamine Derivatives: Synthesis and in Vitro Cytotoxicity

Synthesis, characterization, and cytotoxicity of new types of binuclear platinum(II) complexes

Synthesis, characterization and cytotoxicity of iodo-bridged binuclear platinum(II) complexes.

Synthesis, Cytotoxicity, Induction of Apoptosis, and Interaction with DNA of Dinuclear Platinum(II) Complexes

Synthesis and Biological Activity of Binuclear Platinum Complexes Containing Two Monofunctional Cis-[Pt(Nh3)(2)Cl](+) Units Bridged by 4,4 '-Dipyridyl Selenides or Sulfides

Palladium(II) Complexes with N,N′-Dialkyl-1,10-phenanthroline-2,9-dimathanamine: Synthesis, Characterization and Cytotoxic Activity

Synthesis and in vitro antiproliferative activity of platinum(II) complexes with N-monoalkyl 1R,2R-diaminocyclohexane as ligands.

Synthesis, Antiproliferative Activity and Dna Binding Study of Mixed Ammine/Cyclohexylamine Platinum(Ii) Complexes with 1-(Substituted Benzyl) Azetidine-3, 3-Dicarboxylates

Synthesis, invitro Cytotoxicity, and Interaction with DNA of Platinum(II) Complexes with N-Monocycloalkyl Derivatives of 1R,2R-Diaminocyclohexane as Carrier Ligands

Synthesis, Cytotoxicity, and Apoptosis Induction Study of Antitumor Dinuclear Platinum(ii) Complexes.

Study on the Cytotoxic Activity of Platinum(ii) Complexes of (1 R ,2 R )- N 1 -Cyclopentyl-1,2-cyclohexanediamine with Substituted Malonate Derivatives

Synthesis and Biological Evaluation of Platinum(ii) Complexes Containing (1R,2r)-N1-alkyl-1,2-diaminocyclohexane and D-(+)-camphorate Ligands

Modulating the Anticancer Activity of Square‐Planar Platinum (II) Complex by Its Chelated Diphosphine

Platinum(II) Compounds Bearing Bone-Targeting Group: Synthesis, Crystal Structure and Antitumor Activity.

Synthesis and in Vitro Cytotoxicity of Novel Hydrophilic Chiral 2-Alkoxy-1,4-butanediamine Platinum (II) Complexes.

Study on the cytotoxic activity of platinum(II) complexes of (1R,2R)-N(1)-cyclopentyl-1,2-cyclohexanediamine with substituted malonate derivatives.

Antitumor Platinum(ii) Complexes of N-cyclobutyl-1R,2R-diaminocyclohexane with Dicarboxylates As Leaving Groups

Synthesis, Characterization and Antitumor Activity of New Type Binuclear Platinum(ii) Complexes.

Novel Cisplatin-Type Platinum Complexes and Their Cytotoxic Activity

Antitumor Platinum(II) Complexes with 1,10-phenanthroline and Hydrophilic Alkoxyacetates as Ligands.

Synthesis, Characterization, and Antitumor Biological Evaluation of Novel Fluorine‐containing Platinum (IV) Complexes